Brief: Sprint Bioscience Q3 Oper Result Swings To Profit Of SEK 28.4 Mln
Oct 25 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q3 NET SALES SEK 39.6 MILLION VERSUS SEK 0 MILLION YEAR
AGO
* Q3 OPERATING PROFIT SEK 28.4 MILLION VERSUS LOSS SEK 13.5
MILLION YEAR AGO
Source text for Eikon: ID:nMFN9rLnZk
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln